SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis

Volume: 33, Issue: 3
Published: May 1, 2020
Abstract
Dermatologic TherapyVolume 33, Issue 3 e13435 Therapeutic Hotline: Letter SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis Antonella Di Cesare, Antonella Di Cesare orcid.org/0000-0002-1001-4604 Department of Health Sciences, Section of Dermatology, University of Florence, Florence, ItalySearch for more papers by this authorGreta Tronconi, Greta Tronconi Department of Health Sciences, Section of Dermatology,...
Paper Details
Title
SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis
Published Date
May 1, 2020
Volume
33
Issue
3
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.